An analysis of 2 pharmacovigilance databases revealed a high prevalence of azacitidine-related adverse events in patients with MDS or AML.

There is no FDA-approved topical formulation of finasteride, and compounded topical finasteride products do not have ...

That is why the current wave of fake Ozempic-style drugs now circulating in the U.S by unlicensed and often foreign companies ...

A new study published today by the Ethics and Public Policy Center (EPPC) alleges that the abortion pill, mifepristone, is ...

As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...

The US FDA’s Adverse Event Reporting System has recorded a minuscule percentage, less than 1%, of Botox users reporting depressive symptoms. Most of these cases involved patients being treated ...

On the FDA’s Adverse Events Reporting System, a public dashboard, there are hundreds of reports from 2024 of eye disorders tied to Ozempic, though the FDA warns the dashboard data may contain ...

In 2024, the Centers for Medicare & Medicaid Services ("CMS”) finalized a Medicare reimbursement pathway for personal ...

Susan Aaron was an active 74-year-old retiree with Alzheimer’s who was told she might experience extreme fatigue and terrible headaches if she tried a new drug from Eisai Co. that promised to slow the ...